Navigation Links
Stem cells in neurodegeneration: challenges and future neurotherapeutic prospects
Date:6/16/2014

Researchers at the University of Florida, USA, led by Dr. K. Wang have demonstrated that inhibition of Rho-associated kinase (ROCK) and subsequent cofilin dephosphorylation is mediating neurite outgrowth in PC12 cells. The lack of axonal regeneration in adult central nervous system (CNS) is one of the main cause of neurodegenerative disorders. Thus ROCK inhibition mediated neurite outgrowth is clinically relevant to treat CNS diseases such as Alzheimer's disease, spinal cord injury, traumatic brain injury and stroke (Zhang et al., 2006).

In a follow up study by Prof. W.S. Poon and Dr. P.K. Lam's team from The Chinese University of Hong Kong and Dr. Wang's group, they successfully transplanted mesenchymal stem cells (MSCs) to the brain by topical application in an experimental traumatic brain injury model. Indeed, MSCs delivered to the brain surface were able to migrate to the damaged TBI site. This novel approach makes up for the numerous drawbacks associated with systemic infusion. Moreover, MSCs are capable of neurorepair and neuroprotection, which make their successful transplantation even more significant (Lam et al., 2013).

A combination of these different results can be therapeutically valuable to treat neurodegenerative disorders. As illustrated in this mini-review published in Neural Regeneration Research, Vol. 9, No.: "other and our laboratories are increasingly focusing on combining the use of pharmacological agents (such as Rho-associated kinase (ROCK) inhibitors or other growth factors (such as BDNF) and stem cell treatment to enhance the survivability and/or differentiation capacity of transplanted stem cells in neurotrauma or other neurodegeneration animal models". Nonetheless, the author highlighted the fact that "we still haven't fully grasped the concept of neurogenesis and how it really works", although it is primordial if we want to conceive new therapeutic techniques for neurodegenerative diseases and injuries.


'/>"/>
Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Related biology news :

1. Proliferation cues natural killer cells for job change
2. Guidelines needed for creating germ cells in vitro, Cornell, JAX scientists state
3. Coral, human cells linked in death
4. New class of nanoparticle brings cheaper, lighter solar cells outdoors
5. Specific protein may help beta cells survive in type 1 diabetes
6. Tangled path of Alzheimers-linked brain cells mapped in mice
7. Scientists reveal details of calcium safety-valve in cells
8. Stem cells hold keys to bodys plan
9. Stem cells found to play restorative role when affecting brain signaling process
10. First demonstration in human cells of chromosomal translocations that cause certain cancer
11. MU scientists successfully transplant, grow stem cells in pigs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem cells in neurodegeneration: challenges and future neurotherapeutic prospects
(Date:1/11/2017)... DES MOINES, Iowa , Jan. 11, 2017 /PRNewswire/ ... another industry first with the release of its patent-pending ... to quickly and reliably perform calibrations, securely upload data ... more flexibility for the customer. "Fighting drunk ... not only for the public at large, but also ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced ... "Digital Life Alliance" established by iCarbonX, the ... to build a "Global Digital Health Ecosystem that ... a combination of individual,s biological, behavioral and psychological ... agreement between the companies, SomaLogic will provide proteomics ...
(Date:1/4/2017)... 2017  CES 2017 – Valencell , the ... announced the launch of two new versions of ... biometric sensor modules that incorporate the best of ... expertise. The two new designs include Benchmark BE2.0, ... and Benchmark BW2.0, a 2-LED version of its ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... PARSIPPANY, N.J. , Jan. 20, 2017 /PRNewswire/ ... the "Company"), a company that provides clinically useful ... that it has entered into a securities purchase ... aggregate of 855,000 shares of common stock in ... placement, the Company has agreed to sell to ...
(Date:1/20/2017)... ... ... The two newest companies to join the University City Science Center’s Port ... The Wistar Institute, and Sanguis, launched by a trio of students from the University ... is developing a treatment for a chronic viral infection and its associated diseases, with ...
(Date:1/20/2017)... ... January 20, 2017 , ... SpineFrontier, ... next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System (part ... SpineFrontier is focused on technique driven product solutions that provide maximum efficiency ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
Breaking Biology Technology: